Ebola virus disease [Internet]. https://www.who.int/en/news-room/fact-sheets/detail/ebola-virus-disease. Accessed 16 Mar 2019.
Barry M, Traoré FA, Sako FB, Kpamy DO, Bah EI, Poncin M, et al. Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features. Med Mal Infect. 2014;44(11–12):491–4.
CAS
PubMed
Google Scholar
Hunt L, Gupta-Wright A, Simms V, Tamba F, Knott V, Tamba K, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015;15(11):1292–9.
CAS
PubMed
Google Scholar
Arranz J, Lundeby KM, Hassan S, Fuentes LMZ, Garcés PSJ, Haaskjold YL, et al. Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: Challenges in the later stages of the 2014 outbreak. BMC Infect Dis. 2016;16(1):308.
PubMed
PubMed Central
Google Scholar
de Wit E, Kramer S, Prescott J, Rosenke K, Falzarano D, Marzi A, et al. Clinical chemistry of patients with Ebola in monrovia. Liberia J Infect Dis. 2016;214(suppl 3):S303–7.
PubMed
Google Scholar
Li W-G, Chen W-W, Li L, Ji D, Ji Y-J, Li C, et al. The etiology of Ebola virus disease-like illnesses in Ebola virusnegative patients from Sierra Leone. Oncotarget. 2016;7(19):27910–5.
PubMed
PubMed Central
Google Scholar
Waxman M, Aluisio AR, Rege S, Levine AC. Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2017;17(6):654–60.
PubMed
Google Scholar
WHO | Optimized Supportive Care for Ebola Virus Disease [Internet]. WHO. http://www.who.int/csr/resources/publications/optimized-supportive-care/en/. Accessed 9 Mar 2020.
Ansumana R, Jacobsen KH, Sahr F, Idris M, Bangura H, Boie-Jalloh M, et al. Ebola in Freetown area, Sierra Leone–a case study of 581 patients. N Engl J Med. 2015;372(6):587–8.
CAS
PubMed
Google Scholar
Bah EI, Lamah M-C, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry. Guinea N Engl J Med. 2015;372(1):40–7.
CAS
PubMed
Google Scholar
Dallatomasina S, Crestani R, Sylvester Squire J, Declerk H, Caleo GM, Wolz A, et al. Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health TM IH. 2015;20(4):448–54.
PubMed
Google Scholar
Damkjær M, Rudolf F, Mishra S, Young A, Storgaard M. Clinical features and outcome of Ebola virus disease in pediatric patients: a retrospective case series. J Pediatr. 2017;182:378-381.e1.
PubMed
Google Scholar
Gignoux E, Azman AS, de Smet M, Azuma P, Massaquoi M, Job D, et al. Effect of artesunate-amodiaquine on mortality related to Ebola virus disease. N Engl J Med. 2016;374(1):23–32.
CAS
PubMed
Google Scholar
Guimard Y, Bwaka MA, Colebunders R, Calain P, Massamba M, De Roo A, et al. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S268-273.
PubMed
Google Scholar
Leligdowicz A, Fischer WA, Uyeki TM, Fletcher TE, Adhikari NKJ, Portella G, et al. Ebola virus disease and critical illness. Crit Care Lond Engl. 2016;20(1):217.
Google Scholar
Levine AC, Shetty PP, Burbach R, Cheemalapati S, Glavis-Bloom J, Wiskel T, et al. Derivation and internal validation of the Ebola prediction score for risk stratification of patients with suspected ebola virus disease. Ann Emerg Med. 2015;66(3):285-293.e1.
PubMed
Google Scholar
Liddell AM, Davey RT, Mehta AK, Varkey JB, Kraft CS, Tseggay GK, et al. Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States. Ann Intern Med. 2015;163(2):81–90.
PubMed
PubMed Central
Google Scholar
Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371(25):2402–9.
CAS
PubMed
Google Scholar
Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis. 1999;179:S18-23.
PubMed
Google Scholar
Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371(22):2092–100.
CAS
PubMed
PubMed Central
Google Scholar
Shao X, Ren W, Zhou F. Clinical presentation and care of patients with Ebola virus disease in the china Ebola treatment unit. Liberia Jpn J Infect Dis. 2017;70(1):32–7.
PubMed
Google Scholar
Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, et al. Clinical Management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374(7):636–46.
CAS
PubMed
PubMed Central
Google Scholar
Ebola Situation Reports | Ebola [Internet]. http://apps.who.int/ebola/ebola-situation-reports. Accessed 28 Sep 2019.
Akpovwa H. Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity. Cell Biochem Funct. 2016;34(4):191–6.
CAS
PubMed
PubMed Central
Google Scholar
Al-Bari MAA. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect. 2017;5(1):e00293.
PubMed
PubMed Central
Google Scholar
Bishop BM. Potential and emerging treatment options for Ebola virus disease. Ann Pharmacother. 2015;49(2):196–206.
CAS
PubMed
Google Scholar
Kouznetsova J, Sun W, Martínez-Romero C, Tawa G, Shinn P, Chen CZ, et al. Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect. 2014;3(12):e84.
CAS
PubMed
PubMed Central
Google Scholar
Long J, Wright E, Molesti E, Temperton N, Barclay W. Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res. 2015;4:30.
PubMed
PubMed Central
Google Scholar
Zilbermintz L, Leonardi W, Jeong S-Y, Sjodt M, McComb R, Ho C-LC, et al. Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting. Sci Rep. 2015;5:13476.
CAS
PubMed
PubMed Central
Google Scholar
Sakurai Y, Sakakibara N, Toyama M, Baba M, Davey RA. Novel amodiaquine derivatives potently inhibit Ebola virus infection. Antiviral Res. 2018;160:175–82.
CAS
PubMed
PubMed Central
Google Scholar
Dowall SD, Bosworth A, Watson R, Bewley K, Taylor I, Rayner E, et al. Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model. J Gen Virol. 2015;96(12):3484–92.
CAS
PubMed
PubMed Central
Google Scholar
Falzarano D, Safronetz D, Prescott J, Marzi A, Feldmann F, Feldmann H. Lack of protection against ebola virus from chloroquine in mice and hamsters. Emerg Infect Dis. 2015;21(6):1065–7.
CAS
PubMed
PubMed Central
Google Scholar
Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, et al. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS ONE. 2013;8(4):e60579.
CAS
PubMed
PubMed Central
Google Scholar
Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, et al. Evaluation of Ebola virus inhibitors for drug repurposing. ACS Infect Dis. 2015;1(7):317–26.
CAS
PubMed
Google Scholar
Garbern SC, Yam D, Aluisio AR, Cho DK, Kennedy SB, Massaquoi M, et al. Effect of mass artesunate-amodiaquine distribution on mortality of patients with Ebola virus disease during west african outbreak. Open Forum Infect Dis. 2019. https://doi.org/10.1093/ofid/ofz250.
Article
PubMed
PubMed Central
Google Scholar
Roshania R, Mallow M, Dunbar N, Mansary D, Shetty P, Lyon T, et al. Successful implementation of a multicountry clinical surveillance and data collection system for Ebola virus disease in West Africa: findings and lessons learned. Glob Health Sci Pract. 2016;4(3):394–409.
PubMed
PubMed Central
Google Scholar
Aluisio AR, Yam D, Peters JL, Cho DK, Perera SM, Kennedy SB, et al. Impact of intravenous fluid therapy on survival among patients with ebola virus disease: an international multisite retrospective cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;70(6):1038–47.
Google Scholar
Vitamin A Supplementation Was Associated with Reduced Mortality in Patients with Ebola Virus Disease during the West African Outbreak | The Journal of Nutrition | Oxford Academic [Internet]. https://academic.oup.com/jn/article/149/10/1757/5527780. Accessed 20 Jun 2020.
International Medical Corps. Standard clinical/psychosocial procedures for Ebola treatment unit (ETU) operations. Los Angeles: International Medical Corps; 2016.
Google Scholar
BinaxNOW Malaria - Alere is now Abbott [Internet]. https://www.alere.com/en/home/product-details/binaxnow-malaria.html. Accessed 28 Mar 2020.
Mulangu S, Dodd LE, Davey RT, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293–303.
CAS
PubMed
Google Scholar
RStudio [Internet]. https://rstudio.com/. Accessed 28 Oct 2019.
Skrable K, Roshania R, Mallow M, Wolfman V, Siakor M, Levine AC. The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study. PLoS Negl Trop Dis. 2017;11(7):e0005700.
PubMed
PubMed Central
Google Scholar
Yam D, Aluisio AR, Perera SM, Peters JL, Cho DK, Kennedy SB, et al. Association between multivitamin supplementation and mortality among patients with Ebola virus disease: an international multisite cohort study. Afr J Emerg Med. 2020;10(1):23–9.
PubMed
PubMed Central
Google Scholar
Aluisio AR, Perera SM, Yam D, Garbern S, Peters JL, Abel L, et al. Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in Ebola virus disease: a multinational retrospective cohort study. Trop Med Int Health TM IH. 2020;25(4):433–41.
CAS
PubMed
Google Scholar
Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, Onyango CO, et al. Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;63(8):1026–33.
Google Scholar
Ekins S, Freundlich JS, Coffee M. A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus. F1000Res. 2014;3:277.
PubMed
PubMed Central
Google Scholar
Goyal S, Binnington B, McCarthy SDS, Desmaële D, Férrié L, Figadère B, et al. Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives. F1000Res. 2020;9:268.
CAS
PubMed
PubMed Central
Google Scholar
Clinical management of patients with viral haemorrhagic fever: A pocket guide for front-line health workers | ENN [Internet]. https://www.ennonline.net/vhfpocketguide. Accessed 28 Sep 2019.
Trampuz A, Jereb M, Muzlovic I, Prabhu RM. Clinical review: severe malaria. Crit Care. 2003;7(4):315.
PubMed
PubMed Central
Google Scholar